BNP/CALL/CVS HEALTH/100/0.1/19.12.25 Share Price

Warrant

DE000PC25WR4

Market Closed - Boerse Frankfurt Warrants 01:20:28 01/06/2024 am IST
0.12 EUR +33.33% Intraday chart for BNP/CALL/CVS HEALTH/100/0.1/19.12.25
1 month-36.84%
3 months-61.29%
Date Price Change
31/24/31 0.12 +33.33%
30/24/30 0.09 +21.62%
29/24/29 0.074 +2.78%
28/24/28 0.072 -10.00%
27/24/27 0.08 +1.27%

Real-time Boerse Frankfurt Warrants

Last update May 01, 2024 at 01:20 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC25WR
ISINDE000PC25WR4
Date issued 10/01/2024
Strike 100 $
Maturity 19/12/2025 (566 Days)
Parity 10 : 1
Emission price 0.47
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.54
Lowest since issue 0.051
Spread 0.02
Spread %14.29%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
59.6 USD
Average target price
70.17 USD
Spread / Average Target
+17.73%
Consensus